Introduction
Women play an increasing role in the provision of medical care; young physicians of both sexes enter the relatively new specialty of family practice, and physi cians who have been in practice for some time tend to delay retirement. At the same time, new discoveries in medication therapy are announced with great frequency. Therefore, it is of interest to know whether a changing population of physicians affects the number and kinds of drugs prescribed. If differences by sex and age of the physician do exist, are they simply the results of the structure of the physician's practice?
In this report drug utilization statistics are presented based on the relationship of the sex of the office-based physician and the year of medical school graduation to selected visit characteristics: sex and age of the patient, status and duration of the visit, major reason for the visit, and the type ofphysician's practice. An examina tion of these data indicated that the structure of the practice was more likely to influence drug utilization than was the sex of the physician or the year of medical school graduation.
The data were gathered in 1980 by the National Center for Health Statistics by means of the National Ambulatory Medical Care Survey (NAMCS), a prob ability sample survey conducted annually through 1981 by the Division ofHealth Care Statistics. Brief informa tion about the source of the data, sampling errors, and definitions of terms are provided in the technical notes at the end of this report. A complete description of the survey including limitations and definitions was pub lished in Vital and Health Statistics, Series 13, No.
The methodology used to collect and process the drug information is described in Vital and Health Sta tistics, Series 2, No. 90.2
Only physicians engaged in general and family prac tice were used in this analysis to control for the effect of physician specialty on the nature of drug prescription. General and family practitioners who have a doctor of osteopathy (D. O.) degree were not included because data on the age, sex, or year of the physician's medical school graduation were not available.
The Patient Record form used in the 1980 survey is reproduced in figure 1. Up to eight specific drugs, either new or continued during the visit may be recorded by the physician in item 11, parts a and b. In order to present accurately what the physician ordered, prescribed, or provided, drug mentions used in this report are based on the physicians' entries on the Patient Record forms. These entries were brand or generic names of prescription or nonprescription drugs, though in some instances the physician recorded a therapeutic effec~ for example, " allergy relief."
Visit characteristics
Previous reports from NAMCS have demonstrated that drug utilization statistics vary widely with physician specialty and case-mix. s-s Therefore, when analyzing drug utilization patterns by variables such as physician sex and year of graduation, it is important to examine other factors that may contribute to differences. The data presented in tables 1 and 2 are for selected patient visit variables that could influence drug prescribing. They are presented to enhance and clari~ the interpre tation of drug utilization presented later. The following are noteworthy findings from tables 1 and 2 that maybe . factors contributing to drug use differences by sex of the physician and year of graduation from medical school. Female physicians treated proportionately more new patients (27 percent) than males did (11 percent).
Proportionately more visits involving nonillness care (general examinations, gynecolo~cal examinations, well-baby, and so forth) took place in female physi cians' offices (25 percent) than in male physicians' @ offices (16 percent).
Female physicians spent some time in face-to-face encounter with virtually all their patients, while 3 per- figure 3 .
�
The most professionally active physicians of both sexes were those who graduated in the period 195 l-60, but male physicians saw more patients in a typical work-week than females did, regardless of the year of graduation. 
Drug utilization rates
Two measures of drug utilization are used in this report the percent of drug visits and the drug intensity rate. The percent of drug visits refers to the percent of visits in which one or more drugs were ordered or pro vided. The drug intensity rate is the average number of drugs ordered during drug visits. It is obtained by divid ing the number of drug mentions by the number of drug visits. These drug utilization rates by the sex of the phy sician and the year of medical school graduation (in 10-year intervals) in terms of the same practice variables used to describe the visit estimates shown in table 1 are presented in tables 3-5. The percent distribution of drug mentions by the precise number of medications is shown in table 6.
Sex of physician m
In general. differences in the utilization rates of female&d male physicians were not statistically signif icant. Differences in rates based on the sex of the patient were also not statistically significant. Although female physicians treated proportionately more female patients than male physicians did, they used drugs to treat fe male patients at about the same rate as their male counterparts. Male physicians had a higher proportion of patients over 65 years of age than female physicians did. but pr~ portionally fewer of those visits resulted in drug therapy than those to female physicians (84 percent of visits to male physicians, compared with 97 percent to females). However, the average number of drugs (drug intensity rate) prescribed during those visits was about the same for all physicians. Similarly, the drug intensity rates for patients under 25 years of age, who were more likely to be treated by female physicians than by males, were not statistically different by sex of the physician.
Age of patient
Regardless of the sex of the physician, patients seen before were more likely to have drug visits than new patients were. However, male physicians ordered more drugs during drug visits by returning patients than by new patients. The drug intensity rates for new and retur ningpatients did not differ significantly when the physi cian was a female. However, when the major reason for the patient's visit was a routine chronic problem, about � 91 percent of visits for such care given by female physi cians resulted in a drug prescription, compared with 84 percent of those by male physicians, a statistically sig nificant difference.
Female physicians also tended to prescribe one or more drugs proportionately more often during nonillness visits (69 percent] than male physicians did (49 percent). The drug intensity rates for the routine care of chronic problems and for nonillness care were also higher for female physicians than for males. These results may be due in part to the relatively larger number of female patients seen by female physicians. Also, a higher proportion of female physicians' visits were for examina tions (23 percent) than male physicians were (15 percent). Chronic genitourinary problems treated during women's ofllce visits usually require medication therapy while visits for gynecological examinations are likely to include contraceptive prescription. Vitamins are com monly used for prenatal care, which is a leading diag nosis in the nonillness category. For both female and male physicians the lowest drug intensity rate was associated with very short visits (less than 6 minutes). Otherwise, the average number of drugs prescribed varied only slightly with the longer duration of the visit. Female physicians were more likely than males were to prescribe at least one drug when the visits lasted from 11 to 30 minutes. Because female physicians had a higher proportion of visits with a duration of 16 minutes or more, it may be that the utili zation of drug therapy contributed to the greater visit length.
In comparing drug visits by type of practice for male physicians only, it was found that one or more drugs were mentioned in proportionally more visits to those in solo practice (78 percent) than to those in other types of practice (70 percent). This difference was not statisti cally significant for female physicians. However, female physicians in multiple practices had a higher proportion of c$ug visits than males in multiple practice arrange ments did.
Year of graduation
It was shown previously that older physicians tended to treat older patients, while recent graduates from med ical school tended to treat younger patients. An earlier reports indicated a high correlation between the age of the patient and drug utilization, with rates increasing with increasing age. The current study results reflect these findings. Physicians who graduated before 1961 were more likely to include one or more drugs than those who graduated in later years were. The most recent graduates (197 1-80) prescribed, on the average, fewer drugs per drug visit than their older counterparts did. They also had the highest proportion of visits with only one drug prescribed. However, their drug intensity rates for patients 45 years of age and over increased with increasing age as did those of other physicians, thus 1A "Is,t ,n whjch one or more drugs were ordered.
providing evidence that the rate of drug use depends on proportions of drug visits for nonillness care and postthe age of the patient and not the age of the physician. surgery or postinjury were lowest among all major reaFor all medical school graduates, except the 1971-sons for visit regardless of the physician's year of grad-80 group, proportions of drug visits were higher for old uation. Physicians in practice the longest (graduated patients returning to the same physician for care of a before 1941 ) were the least likely to have drug visits for continuing probIem than for new patients. On the other noniIlness care (35 percent). This was probably related hand, the 197 1-80 graduates were more likely to preto the fact that nonillness care given by older physicians scribe one or more drugs during initial visits (which was usually for a routine physicaI examination, while were likely to be made by young rather than more mature younger physicians provided more pediatric (immuni patients) than during visits by patients returning for zations, and so forth) and prenatal care. continuing care.
Proportions of drug visits did not vary appreciably Physicians who graduated after 1960, and who had with changing duration intervals regardless of the year proportionately more patients under 25 years of age of graduation. Only very long visits (31 minutes or than other physicians did, had lower proportions of drug longer) had proportionately fewer drug visits than other visits for care of acute or chronic problems than physidurations did. However, the average number of drugs cians who graduated before 1961 did. As expected, ordered during drug visits to some groups was related to � the duration of the visit. For physicians who graduated before 1961 the drug intensity rate for visits lasting 11 minutes or more was higher than that for visits lasting less than 11 minutes. This difference was not statisti cally significant for physicians who graduated in later years. One possible explanation for this is that both visit duration and drug utilization increase with increasing patient age group, and physicians who graduated before 1961 see proportionately more older patients than younger physicians do.
Therapeutic categories

Sex of physician
Each drug named by the physician in NAMCS is classified according to its desired therapeutic effect based on the classification system of the American Hospital Formulary Service.G The distribution of drug mentions by therapeutic category is shown in table 7.
The use of certain kinds of drugs tended to follow the case-mix pattern of the physician groups. The leading category used by physicians of both sexes was central nervous system drugs. Serums, toxoids, and vaccines (13 percent) was the next largest category prescribed by female physicians, and it was significantly greater than the 3 percent of the same drugs used by male physicians. For male physicians the second ranking therapeutic group was anti-infective agents (17 percent), which exceeded the use of such drugs by female physicians ( 10 percent). Other differences between therapeutic cate gories used by female and male physicians were not statistically significant.
There were some within-category differences depend ing on the sex of the physician. In the central nervous system group, no respiratory and cerebral stimulants * were prescribed by females. In the hormones and syn thetic substitutes group, males used proportionately more adrenals and androgens than females did, while females ordered proportionately more contraceptives. These results reflect the distribution of patient visits by sex of the patients likely to visit female and male phy sicians.
Year of graduation
As might be expected considering the age distri butions oftheirpatients, physicians who graduated before 1941 made greater use of cardiovascular drugs and diuretics than their younger counterparts did. Physicians who graduated before 1961 were more likely to prescribe central nervous system drugs than those who graduated later were. The most recent graduates were more likely to use antihistamines and skin and mucous membrane preparations, reflecting the higher proportions of young and female patients who visited them.
Specific drugs
The specific drugs most frequently prescribed by general and family practitioners (including doctors of osteopathy) were listed by age of the patient in Ad vance Data No. 86.4 A comparison of those data with the drug lists generated by the physicians grouped by � sex of the physician and year of graduation in the current analysis revealed few differences among the groups in the drugs named or their relative standing. .?.lnc,ude~ ~"tineoPlastic ~ge"t%, diag"~~tic agents, e"ZymeS, gold compounds, heavy metal antagonists, local anesthetics, oxytocics, unclassified therapeutic a9entS, pharmaceutics aids, and therapeutic category undetermined.
@
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Discussion
This study was limited because of the small number of female physicians in the sample. Females constitute approximately 5 percent of the office-based general and family practitioners in the NAMCS universe. The female general and family practitioners (M. D.'s, doctors of medi cine) accounted for 22 percent of all female physicians who reported visits in NAMC S: The males accounted for21 percent of the male physicians in the same specialty. However, the relatively large sampling error associated with the small size of the female sample made it difficult to detect differences.
Most of the differences in drug utilization between female and male physicians can be attributed to the differences in the demographic characteristics of their patients and the diagnoses commonly associated with them. Although the study was restricted to only one specialty, it is apparent that in general and family prac tice, case-mix is influenced by the sex of the physician.
Similarly, case-mix also depends on the age of the physician. A medical practice is built over a period of time and it is natural for older patients to continue seeking their health care from the same established physicians. The caseload of the newly graduated physi cian, on the other hand, typically consists of young patients, many of them seeing a physician for the first time for preventive care or for self-limiting conditions. These differences in visit characteristics were noticeable in the distribution of drugs by therapeutic category. As expected, there was a strong correlation between case-mix and the categories of drugs most frequently used. It is noteworthy, however, that in the choice of specific drugs, the age of the physician had no apparent effect. Physicians who graduated over 40 years ago prescribed the same brand name drugs, many of them only recently developed, as those who graduated in more recent decades did. Continuing medical education courses and seminars, often required for board certifica tion, is one factor in the updating of the physician's medical knowledge. But pharmaceutical discoveries proliferate at a rapid pace, and the manufacturers also contribute to the modernization of the physician's treat ment arrnarnentarium through their representatives and literature. One conclusion that might be drawn from the results of this study suggests that the motivation to acquire new drug information is common to all age physicians.
4National Center for Health Statistics, B. K. Cypress: Drug utiliza tion in ofFicevisits to primary care physicians, National Ambulatory Medical Care Survey, 1980 . AdvanceDataFrom VifalandHealfh Statistics, No. 86. DHHS Pub. No. (PHHS) 82-1250 . Public Health Service, Hyattsville, Md. Oct. 8, 1982 
Technical notes Source of data and sample design
The information presented in this report is based on data collected by the National Center for Health Statis tics (NCHS) through its National Ambulatory Medical Care Survey (NAMCS) during 1980. The target uni verse of NAMCS includes.office visits made within the coterminous United States by ambulatory patients to nonfederally employed physicians who are principally engaged in ofilce practice, but not in the specialties of anesthesiology, pathology, or radiology. Telephone con tacts and nonofllce visits are excluded.
NAMCS utilizes a multistage probability sample design that involves samples of primary sampling units (PSU'S), physicians' practices within PSU'S, and patient visits within physician practices. For 1980 a sample of 2,959 non-Federal, office-based physicians was selected from master files maintained by the American Medical Association and the American Osteopathic Associa tion. The physician response rate for 1980 was 77.2 percent. Sampled physicians were asked to complete Patient Records (figure 1) for a systematic random sample of ofllce visits taking place during a randomly assigned weekly reporting period. During 1980, respond ing physicians completed 46,081 Patient Records, on which they recorded 51,372 drug mentions. Charac-. teristics of the physician's practice, such as primary specialty and type of practice, were obtained during an induction interview. The National Opinion Research Center, under contract to NCHS, was responsible for the survey's field operations.
For a more detailed discussion of the limitations, qualifications, and definitions of the data collected in the NAMCS, see Vital and Health Statistics, Series 13. No. 66.1 Estimates presented in this report differ from the esti mates reported in the National Medical Care Utilization and Expenditure Survey (NMCUES), another program of NCHS. The variation in estimates is due to differences in survey populations, data collection meth odology, and definitions. The NMCUES, cosponsored by NCHS and the Health Care Financing Administration (HCFA), is a national panel survey of households in which information on visits to physicians' ofilces and hospital outpatient departments was collected. Prelim inary survey data as well as a discussion of the survey methodology are forthcoming from NCHS and HCFA.
Sampling errors and rounding of numbers
The standard error is primarily a measure of the sampling variability that occurs by chance because only NOTE: A list of references follows the text, 9 a sample, rather than the entire universe, is surveyed. The relative standard error of an estimate is obtained by dividing the standard error by the estimate itself and is expressed as a percent of the estimate. Relative standard errors of selected aggregate visit statistics are shown in Table I . Standard errors for estimated percents of visits are shown in table II. Similar standard errors for drug statistics and percents are shown in tables III and IV. Tables I and II should be used to obtain the standard error of a specific drug mention (e.g., Dyazide). Tables  III and IV should be used to obtainthe standard error of a group of drug mentions (e.g., all drugs prescribed for hypertension).
Estimates of office visits have been rounded to the nearest thousand. For this reason detailed figures within tables do not always add to totals. Rates and percents were calculated on the basis of original, unrounded figures and will not necessarily agree precisely with percents calculated from rounded data.
Definitions
An ambulatory patient is an individual presenting himself for personal health services who is neither bedridden nor currently admitted to any health care institu tion on the premises.
A physician eligible for NAMCS is a duly licensed doctor ofmedicine(M.D.) ordoctorofosteopathy (D. O.) currently in ofilce-based practice who spends time in caring for ambulatory patients. Excluded from NAMCS are physicians who are hospital based, physicians who specialize in anesthesiology, pathology, or radiology; physicians who are federally employe~ physicians who treat only institutionalized patients; physicians em ployed full time by an institution; and physicians who spend no time seeing ambulatory patients.
An office is a place that the physician identifies as a location for his ambulatory practice. Responsibility over time for patient care and professional services rendered there generally resides with the individual physician rather than an institution. A visit is a direct personal exchange between an ambulatory patient and a physician or a stti member working under the physician's supervision, for the pur pose of seeking care and rendering health services.
A drug mention is the physician's entry of a phar maceutical agent ordered or provided-by any route of administration-for prevention, diagnosis, or treatment. Generic as well as brand-name drugs are included, as are nonprescription as well as prescription drugs. Along with all new drugs, the physician also records continued medications if the patient was specifically instructed during the visit to continue the medication. 
